THE EDUCATIONAL EQUALITY INSTITUTE
US 501(C)(3) EIN 33-2331817 · NORWAY ORG 928 776 719

ONE CONNECTION FOR ORGANISATIONS

The pilot is designed. It needs partners.

A registered feasibility study of structured video peer support for transplant survivors: protocol drafted, platform in production, measures validated. What it needs now is a principal investigator, pilot sites, and recruitment partners.

What we bring. What we ask.

This is not a vendor pitch. TEEI is a nonprofit bringing a built platform and a drafted protocol; partners bring the clinical setting the study must live in.

PARTNERSHIP TERMS · THE WHOLE DEAL, ONE CARDDRAFT, FOR DISCUSSION

A platform in production: live 1:1 video, real-time translation, matching, session logging and outcome tracking, already serving TEEI's education programmes

The clinical setting: 2 to 3 academic transplant centres identifying eligible survivors through their outpatient clinics

A drafted feasibility protocol with validated instruments: UCLA-3, PHQ-9, GAD-7, FACT-BMT, PROMIS social isolation

A principal investigator to shape and own it. The protocol names its PI as TBD on purpose: it is co-designed, not handed over

Trained, supervised peer mentors with clear escalation boundaries: peer support, never presented as therapy

IRB partnership and honest co-authorship of what the study finds, null results included

The funding work: TEEI carries fundraising for the pilot; partnership is free

Recruitment reach: foundations and survivor communities carrying the study to the people it is for

Terms: NO FEES, NO LICENSING, NO PROCUREMENT PROCESS TO SURVIVE. SOURCE: DRAFT PROTOCOL V1.0.

THE STUDY

Designed to be published, not just run.

Feasibility first, honestly: can this population be recruited, retained, and served by video peer support, and do the outcome signals point the right way. Registered before the first participant enrols, reported whatever it finds.

Where this stands: the protocol is drafted. A principal investigator and clinical partners are being confirmed. The study has not begun.

STUDY SYNOPSISDRAFT PROTOCOL V1.0
Design
Single-arm feasibility study, pre-post measurement, embedded qualitative component
Population
50 transplant survivors (25 allogeneic, 25 autologous), 3 months to 5 years post-transplant, plus 20 trained peer mentors
Intervention
6 months of structured 1:1 video peer support, biweekly to monthly calls, English or Spanish
Primary outcomes
Feasibility and acceptability: enrolment, retention, session completion, match quality
Secondary
UCLA-3 loneliness, PHQ-9, GAD-7, FACT-BMT quality of life, PROMIS social isolation
Registration
ClinicalTrials.gov, before the first participant enrols; CONSORT pilot extension reporting
FIG. 03 · STUDY TIMELINE, 12 MONTHSDRAFT PROTOCOL V1.0

Months 1-3

Setup, IRB, mentor training

Months 4-9

The intervention: 50 matches, 6 months of structured 1:1 video support

Months 10-12

Analysis and write-up

CLINICALTRIALS.GOV REGISTRATION LANDS BEFORE THE FIRST PARTICIPANT ENROLS

Three kinds of partner.

The registry on this programme lists no partner names yet, and will not until each one approves it. These are the three doors in.

01

Transplant centres

2 to 3 academic centres with active HSCT programmes, identifying eligible survivors through outpatient clinics. The intervention itself is delivered remotely; the clinic's role is identification and referral.

02

A principal investigator

A clinical researcher in transplant survivorship or psychosocial oncology who wants to own a first-of-its-kind feasibility study, shape the final protocol, and publish what it finds.

03

Foundations and communities

Patient foundations and survivor networks carrying recruitment to the people the study is for, and helping shape mentor training with lived experience.

FIG. 04 · THE ENTIRE EVIDENCE BASE, TO SCALEONE DOT = ONE PATIENT EVER STUDIED

574

patients, across 8 studies: every published peer-support study for blood cancers fits on this card. The study you would co-own adds 50 more.

70% of transplant patients have no formal peer support of any kind. This is the population your clinics discharge into that gap every week.

Sources: SYSTEMATIC REVIEW 2022, PEER SUPPORT IN HEMATOLOGIC MALIGNANCY; 70% IS THE REVIEW'S ESTIMATE.

Partnership costs nothing. Free for every clinical partner, like everything else TEEI runs. We are a nonprofit; the study is the point.

NO FEES, NO LICENSING, NO PROCUREMENT PROCESS TO SURVIVE.

If your patients are this population, let us talk.

One conversation to see whether this fits your centre, your research, or your community. The protocol, the platform, and the evidence base are ready to show in full.

THE EDUCATIONAL EQUALITY INSTITUTE · 501(C)(3) · ALL PROGRAMMES ARE FREE

ONE CONNECTION · LAUNCHING 2026 · TRANSPLANT SURVIVORS FIRST